Literature DB >> 10544950

Fatty acid metabolism in human breast cancer cells (MCF7) transfected with heart-type fatty acid binding protein.

C Buhlmann1, T Börchers, M Pollak, F Spener.   

Abstract

The human breast cancer cell line MCF7 does not express heart-type fatty acid binding protein (H-FABP), a marker protein for differentiated mammary gland. MCF7 cells transfected with the bovine H-FABP cDNA expressed the corresponding protein and were characterized by growth inhibition and lower tumorgenicity in nude mice [22]. By enzyme linked immunoassay we now determined the amount of bovine H-FABP in these cells as 638 +/- 80 ng/mg protein and used the transfected cells to study the role of H-FABP in fatty acid metabolism. Compared to control cells the uptake of radioactively labelled palmitic acid and oleic acid into MCF7 cells after 30 or 60 min was increased by 67% in H-FABP expressing transfectants, demonstrating a stimulatory role for this FABP-type in fatty acid metabolism. However, preferential targeting of [14C]oleic acid into neutral or phospholipid classes was not observed by the criterion of high performance thin layer chromatography followed by autoradiography. A reason for the modest increase of fatty acid uptake in H-FABP transfected MCF7 cells may be the basal expression of epidermal-type FABP, which was detected for the first time in these cells. It appears that the small amount of E-FABP expressed in MCF7 cells fulfils the need of the cells for a cytosolic fatty acid carrier under culture conditions and that even high concentrations of another FABP do only slightly increase the uptake due to limitations of fatty acid transport through the plasma membrane or of metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544950     DOI: 10.1023/a:1006986629206

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  42 in total

Review 1.  Cytoplasmic fatty acid-binding proteins: their structure and genes.

Authors:  J H Veerkamp; R G Maatman
Journal:  Prog Lipid Res       Date:  1995       Impact factor: 16.195

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes.

Authors:  H Huynh; L Alpert; M Pollak
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

4.  Intestinal and liver fatty acid binding proteins differentially affect fatty acid uptake and esterification in L-cells.

Authors:  D R Prows; E J Murphy; F Schroeder
Journal:  Lipids       Date:  1995-10       Impact factor: 1.880

5.  Mammary derived growth inhibitor is not a distinct protein but a mix of heart-type and adipocyte-type fatty acid-binding protein.

Authors:  B Specht; N Bartetzko; C Hohoff; H Kuhl; R Franke; T Börchers; F Spener
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

6.  Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.

Authors:  G S Hotamisligil; R S Johnson; R J Distel; R Ellis; V E Papaioannou; B M Spiegelman
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

7.  Differentiation-promoting effects of mammary-derived growth inhibitor (MDGI) on pluripotent mouse embryonic stem cells.

Authors:  A M Wobus; W Zschiesche; R Grosse
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

8.  Differentiational regulation and phosphorylation of the fatty acid-binding protein from rat mammary epithelial cells.

Authors:  S U Nielsen; R Rump; P Højrup; P Roepstorff; F Spener
Journal:  Biochim Biophys Acta       Date:  1994-03-03

9.  Sex differences in hepatic fatty acid uptake reflect a greater affinity of the transport system in females.

Authors:  D Sorrentino; S L Zhou; E Kokkotou; P D Berk
Journal:  Am J Physiol       Date:  1992-09

10.  Members of the fatty acid binding protein family are differentiation factors for the mammary gland.

Authors:  Y Yang; E Spitzer; N Kenney; W Zschiesche; M Li; A Kromminga; T Müller; F Spener; A Lezius; J H Veerkamp
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

View more
  6 in total

1.  Liver and intestinal fatty acid-binding protein expression increases phospholipid content and alters phospholipid fatty acid composition in L-cell fibroblasts.

Authors:  E J Murphy; D R Prows; T Stiles; F Schroeder
Journal:  Lipids       Date:  2000-07       Impact factor: 1.880

2.  Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice.

Authors:  J J F P Luiken; D P Y Koonen; W A Coumans; M M A L Pelsers; B Binas; A Bonen; J F C Glatz
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

3.  Fatty-acid-binding proteins do not protect against induced cytotoxicity in a kidney cell model.

Authors:  A W Zimmerman; J H Veerkamp
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

4.  Challenges in enriching milk fat with polyunsaturated fatty acids.

Authors:  Jennifer Stamey Lanier; Benjamin A Corl
Journal:  J Anim Sci Biotechnol       Date:  2015-06-12

5.  Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injury.

Authors:  Jo-Wen Liu; Manuel Montero; Liming Bu; Marino De Leon
Journal:  J Neurochem       Date:  2014-09-19       Impact factor: 5.372

6.  Transcriptomic signature of bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models.

Authors:  Martin C Abba; Yuhui Hu; Carla C Levy; Sally Gaddis; Frances S Kittrell; Yun Zhang; Jamal Hill; Reid P Bissonnette; Daniel Medina; Powel H Brown; C M Aldaz
Journal:  BMC Med Genomics       Date:  2008-09-11       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.